Search

everythinglearnresearchcommunity

for

Search:↓

Blocking CRF1 receptors improved male hormone levels and reduced testicular tumor size in men with a specific adrenal condition.

Beta-trace protein may help diagnose and predict treatment response in certain nerve disorders.

Farudodstat can prevent hair follicle immune damage linked to alopecia areata.

Vaccines and targeting TrxR variants can help prevent cancer and reduce metastasis.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Deucravacitinib led to full hair regrowth in a severe alopecia areata patient.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Both steroids effectively promote hair growth for at least 9 months.

Tridax procumbens is a plant with many health benefits, including healing, protecting the liver, fighting infections, and promoting hair growth.

Some thymic peptides can increase human hair growth, while others may inhibit it.

PROTAC technology shows promise for cancer treatment but needs more effective E3 ligase recruiters.

Tofacitinib may cause nerve damage in the brain, so monitor for neurological symptoms.

A new mutation in the XEDAR gene might cause a rare skin condition called hypohidrotic ectodermal dysplasia.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Dacomitinib can cause nail and skin issues, but these can be managed without stopping the drug.

The ID2 gene can help distinguish between sensitizers and irritants in skin cells.

Baricitinib may reactivate trichilemmal cysts in people with a history of these cysts.

Topical tacrolimus reduces certain growth factors in hair follicles.

A patient developed nerve problems as a side effect of a hair loss treatment called tofacitinib.

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Switching to ritlecitinib improves hair regrowth and well-being in severe alopecia areata patients.

Upadacitinib can cause hypersensitivity that worsens ulcerative colitis symptoms.

Putting thymidine dinucleotide on newborn mice's skin can delay and reduce skin cancer.

Tofacitinib can temporarily improve hair growth in alopecia universalis, but its effectiveness may decrease over time.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.

Vitamin D receptor helps prevent skin tumors.

Upadacitinib significantly improved a man's severe scalp condition when other treatments failed.